Sanofi's oral teriflunomide no better than Rebif
20 December 2011
Sukaina Virji
Please Login to read the full article.
20 December 2011
Sukaina Virji
sukaina.virji@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Merck Serono ditches cladribine, leaving MS franchise exposed
- Biogen seeks to retain lead in MS market with US BG-12 submission
- Novartis's misfortunes with Gilenya could provide a boost for other MS drug makers
- Bravo or bravado? Teva, Active move baseline to make PhIII oral MS miss a hit
ANALYSIS
Other Informa Analysis
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
